NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to ...
Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...
Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...
Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...
LONDON--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London ...